summari report result close
exceed expect revenu y/i organ
came ahead estim consensu
geographi ep y/i came ahead
consensu estim reflect strong drop-through
sale growth good expens manag lower-than-expect
effect tax rate overal strong quarterli print given
strong busi momentum manag rais organ
revenu guidanc midpoint ep
midpoint prior call
look organ revenu growth ep
full year rais estim reflect compani new
outlook revenu estim
organ ep estim
y/i base ep estim
rais outlook second time year
base syk strong perform date anticip
strength remaind year compani rais
revenu ep outlook worth note second
time year rais guidanc also worth note
began year organ growth outlook
highest initi outlook compani decad
expect organ sale growth rang
prior outlook provid
april compani expect fx estim headwind
full year includ nomin impact one
extra sell day estim
benefit quarter approxim
full year expect ep rang
versu prior outlook compani
expect fx headwind ep full year versu
compani prior expect headwind
ep compani guid rang bracket
consensu prior estim manag note
fx impact ep expect minim continu
expect om improv full year
includ deal relat dilut expect greater benefit
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
report ep cash basi exclud amort
compani data secur llc estim reuter
continu previou page
mako see strong uptak expect continu despit competit place
mako system quarter includ us system includ us
year ago compani global instal base system includ approxim
us mako system util approxim procedur us
notabl level procedur includ mako tka procedur also versu
level procedur see strong implant pull mako system drive
share gain knee interest note see pull across recon portfolio
knee manag explain custom purchas mako knee implant use
procedur hip see strong uptak mako hip includ new
print trident hip cup note call util mako hip procedur double-
digit y/i seen similar trend monthli mako surgeon tracker look ahead believ
mako continu drive implant share gain hip knee manag also note
expect current trend continu anticip much impact competit
time
orthoped adjust organ sale growth y/i came ahead estim
orthoped sale exceed estim compani deliv organ
revenu growth level came ahead estim
result driven strong uptak compani mako tka platform print product
shoulder implant report organ growth y/i led knee versu
hip versu recon capit y/i
trauma extrem sale grew versu manag expect trauma
segment growth improv quarter ahead driven newli launch next gener nail
system call alpha outsid report organ growth y/i reflect strong
growth emerg market
global recon market growth look sequenti big four recon
hip knee implant compani report result make nearli
global recon market result suggest global recon market sequenti
y/i led acceler global hip y/i off-set flat growth global
knee y/i momentum global hip appear led
sequenti improv y/i expect get clariti recon market growth rate
snn report earn
medsurg adjust organ sale growth exceed estim
report medsurg sale exceed estim compani deliv organ
revenu growth level came ahead estim
result driven strong growth across sub-seg instrument busi drove
major upsid rel estim report organ growth y/i led
instrument versu despit tougher sequenti comp driven
compani decis split sale forc earlier year creat dedic sale team
also saw good growth power tool wast manag product within instrument busi
elsewher endoscopi growth versu driven doubl digit growth
video franchis led camera launch novadaq portfolio product
 medic growth versu driven strong growth bed stretcher
includ prevalon primafit outsid us medsurg growth y/i led
china emerg market
neurotechnolog spine organ sale growth miss estim
report segment sale exceed estim compani deliv organ
revenu growth level reflect tougher comparison miss
estim result driven neurotech product off-set integration-rel
disrupt us spine us neurotech growth versu led cmf
craniomaxillofaci hemorrhag ischem stroke product well neuro power instrument
spine continu focu integr complet activ relat product
train cross-sel quarter compani deliv pro-forma sale growth
quarter note exit quarter mid-singl digit growth remain
confid deliv mid-singl digit pro forma sale growth spine full year outsid
us neurotech spine deliv strong organ growth versu driven
demand neurotech product across geographi
oper margin expans back-end load deliv gross margin
contract y/i due price fx busi mix higher medsurg growth modestli
off-set product improv sg sale reflect improv y/i
driven compani transform growth ctg program sale
fairli consist prior year quarter net-net deliv adjust oper margin
y/i reflect oper leverag cost save off-set invest
acquisition-rel dilut call deal relat dilut quarter impli
underli margin improv look ahead maintain outlook net oper
margin expans full year greater net benefit versu given time
price target
price target base ep estim risk thesi includ slower
procedur volum growth increas price pressur delay new product approv
expect deliv organ sale growth high-end med-tech led broad-bas growth
across segment geographi aid execut contribut recent acquisit
incorpor michigan stryker corpor one world largest medic technolog
compani offer orthoped implant well medic surgic equip orthoped implant
account revenu medsurg divis account nearli
neurotechnolog spine account remaind compani report sale billion
